Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1998; 80(04): 705-706
DOI: 10.1055/s-0037-1615448
DOI: 10.1055/s-0037-1615448
Letters to the Editor
A Polymorphism nt 1628G→A (R485K) in Exon 10 of the Coagulation Factor V Gene May Be a Risk Factor for Thrombosis in the Indigenous Thai Population
Further Information
Publication History
Received
15 April 1998
Accepted after revision
18 June 1998
Publication Date:
08 December 2017 (online)
-
References
- 1 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
- 2 Rees DC. The population genetics of factor V Leiden (Arg506Gln). Br J Haematol 1996; 95: 579-86.
- 3 Ishida F, Ito T, Ichikawa N, Shimodaira S, Takamiya O, Furihata K, Kiyosawa K, Kitano K. Arg506Gln factor V mutation is uncommon in Eastern Asian populations. Blood 1995; 86: 917a.
- 4 Sifontes MT, Nuss R, Hunger SP, Wilimas J, Jacobson LJ, Manco-Johnson MJ. The factor V Leiden mutation in children with cancer and thrombosis. Br J Haematol 1997; 96: 484-9.
- 5 Gandrille S, Greengard JS, Alhenc-Gelas M, Juhan-Vague I, Abgrall JF, Jude B, Griffin JH, Aiach M. the French Network on behalf of INSERM. Incidence of activated protein C resistance caused by the Arg 506 Gln mutation on factor V in 113 unrelated symptomatic protein C deficient patients. Blood 1995; 86: 219-24.
- 6 Helley D, Besmond C, Ducrocq R, da Silva F, Guillin M-C, Bezeaud A, Elion J. Polymorphism in exon 10 of the human coagulation factor V gene in a population at risk for sickle cell disease. Hum Genet 1997; 100: 245-8.
- 7 Dahläck B. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management. Semin Hematol 1997; 34: 217-34.